"Several Birds with One Stone": Exploring the Potential of AI Methods for Multi-Target Drug Design

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Drug discovery is a time-consuming and expensive process. Artificial intelligence (AI) methodologies have been adopted to cut costs and speed up the drug development process, serving as promising in silico approaches to efficiently design novel drug candidates targeting various health conditions. Most existing AI-driven drug discovery studies follow a single-tar...

Topics

Open a Topic to create a Post that cites this publication.

• Artificial Intelligence
• Bioinformatics and Genomic Networks
• Cholinesterase and Neurodegenerative Diseases
• Computational Drug Discovery Methods
• Dose-Response Relationship, Drug
• Phenotype
• Precision Medicine

Identifiers and source

Literature Corpus work

bc73b8f3-b2cf-5ba9-bf92-75a4b0efcc14

DOI

10.21203/rs.3.rs-4403135/v1